[The progress of a fibrinolytic therapy with streptokinase, urokinase and warfarin in a thoroughbred with intermittent lameness with special reference to resonance thrombography].

This research article provides an account on a successful treatment of a thoroughbred horse with intermittent lameness using fibrinolytic therapy that involved streptokinase, urokinase and warfarin, monitored through a resonance thrombogram.

Treatment of a Thoroughbred with Lameness

• The research focused on a thoroughbred horse that was suffering from intermittent lameness, a common orthopedic problem in horses characterized by an irregular gait or reluctance to move. It often indicates pain or discomfort, possibly resulting from a variety of underlying conditions such as joint inflammation, ligament damage or bone fractures.
• To treat the condition, the horse was administered a fibrinolytic therapy involving drug agents streptokinase, urokinase and warfarin. Fibrinolytic therapy uses drugs that encourage the breakdown of blood clots and is used to reopen blocked blood vessels, thus promoting better blood flow. Streptokinase and urokinase are enzymes that help dissolve clots, while warfarin is an anticoagulant that prevents new clots from forming.

Monitoring of Fibrinolytic Changes

• The effectiveness of the therapy and the changes it caused in blood coagulation were monitored using a resonance thrombogram. A thrombogram is a diagnostic tool that measures the rate at which blood clots form and dissolve, providing insight into a patient’s coagulation activity and fibrinolytic system.
• Throughout the treatment, accompanying coagulation studies showed the presence of fibrinogen- and fibrin-degradation products, which are markers for blood clot dissolution and indicate the effectiveness of the fibrinolytic therapy.

Successful Outcomes

• The treatment was deemed successful as the horse no longer exhibited any signs of lameness following the end of the therapeutic protocol. Improved mobility was achieved indicating that the blood flow was effectively restored to the horse’s limbs.
• The horse has been standing in a breeding station since March 1988, possibly implying its preserved functionality and well-being after therapy, although the study does not provide in-depth details of the horse’s condition post-treatment.